Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology
Education:
- 2004-2011: İnönü University Faculty of Medicine
- 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
- 2017-2022: Health Sciences University, Medical Oncology
Professional Experience:
- 2016-2017: Bingöl City Hospital, Internal Medicine
- 2021-2022: Health Sciences University, Medical Oncology
- 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
- 2023-2024: Ohio State University, Medical Oncology
- 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital
Clinical Trials, Courses, Certifications:
Clinical Trials:
- 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
- 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)
Courses:
- 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
- 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
- 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
- 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
- 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association
Certifications:
- Ongoing: ECFMG Certification
- 2024: CITI Responsible Conduct of Research (The Ohio State University)
- 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
- 2024: CITI Human Subjects Protection (The Ohio State University)
- 2024: CITI Good Clinical Practice (The Ohio State University)
- 2023: Occupational English Test (OET)
- 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
- 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
- 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016
Memberships:
- American Society of Clinical Oncology (ASCO) - 2022
- Turkish Society of Medical Oncology - 2020